Phase I trial of intravesical gemcitabine in BCG-refractory transitional cell carcinoma of the bladder

被引：0
|
作者：
Dalbagni, G
Russo, P
Sheinfeld, J
Mazumdar, M
Tong, W
Rabbani, F
Donat, SM
Herr, HW
Sogani, P
Depalma, D
Bajorin, D
机构：
来源：
JOURNAL OF UROLOGY | 2002年 / 167卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：186 / 186
页数：1
相关论文
共 50 条
  • [1] Phase II trial of intravesical gemcitabine in BCG-refractory transitional cell carcinoma of the bladder
    Dalbagni, G
    Russo, P
    Ben-Porat, L
    Donat, SM
    Herr, HW
    Bochner, BH
    Bajorin, DF
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 270 - 271
  • [2] Phase II trial of intravesical gemcitabine in BCG refractory transitional cell carcinoma of the bladder
    Dalbagni, G
    Mazumdar, M
    Russo, P
    Sheinfeld, J
    Donat, SM
    Bochner, BH
    Herr, HW
    Sogani, P
    Ginty, J
    Bajorin, DF
    [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 72 - 72
  • [3] Intravesical gemcitabine in BCG-refractory T1G3 transitional cell carcinoma of the bladder: A pilot study
    Gacci, M
    Bartoletti, R
    Cai, T
    Nerozzi, S
    Pinzi, N
    Repetti, F
    Viggiani, F
    Ghezzi, P
    Nesi, G
    Carini, M
    [J]. UROLOGIA INTERNATIONALIS, 2006, 76 (02) : 106 - 111
  • [4] A phase I trial for the use of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) in the treatment of BCG-refractory nonmuscle invasive urothelial carcinoma of the bladder.
    DeCastro, Guarionex Joel
    Sui, Wilson
    Pak, Jamie S.
    Abate-Shen, Corinne T.
    Lee, Shing Mirn
    Anderson, Christopher B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [5] Phase I trial of intravesical gemcitabine in bacillus Calmette-Guerin-refractory transitional-cell carcinoma of the bladder
    Dalbagni, G
    Russo, P
    Sheinfeld, J
    Mazumdar, M
    Tong, W
    Rabbani, F
    Donat, MS
    Herr, HW
    Sogani, P
    dePalma, D
    Bojorin, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) : 3193 - 3198
  • [6] Intravesical gemcitabine in management of BCG refractory superficial transitional cell carcinoma (TCC) of urinary bladder
    Mohanty, N. K.
    Nayak, R. L.
    Arora, R. P.
    Saxena, S.
    [J]. BJU INTERNATIONAL, 2007, 99 : 14 - 14
  • [7] A PHASE I TRIAL FOR THE USE OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) IN THE TREATMENT OF BCG-REFRACTORY NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    DeCastro, Guarionex
    Sui, Wilson
    Pak, Jamie
    Abate-Shen, Cory
    Lee, Shing
    Anderson, Christopher
    Holder, Dara
    McKiernan, James
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E175 - E176
  • [8] Phase II trial of intravesical gemcitabine in bacille Calmette-Guerin-refractory transitional cell carcinoma of the bladder
    Dalbagni, G
    Russo, P
    Bochner, B
    Ben-Porat, L
    Sheinfeld, J
    Sogani, P
    Donat, MS
    Herr, HW
    Bajorin, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2729 - 2734
  • [9] Endovesical treatment with gemcitabine in patients with BCG-refractory superficial bladder carcinoma
    Gunelli, R.
    Frassineti, G. L.
    Giovannini, N.
    Zoli, W.
    Fiori, M.
    Amadori, D.
    Fabbri, P.
    Bercovich, E.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI78 - XI78
  • [10] ENDOVESICAL TREATMENT WITH GEMCITABINE IN PATIENTS WITH BCG-REFRACTORY SUPERFICIAL BLADDER CARCINOMA
    Gunelli, Roberta
    Frassineti, Giovanni Luca
    Giovannini, Noemi
    Zoli, Wainer
    Fiori, Massimo
    Saltutti, Carlo
    Amadori, Dino
    Bercovich, Eduard
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 95 - 96
12345